Investec Bank plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure, submitted on 14th July 2026, covers trading activity that took place on 13th July 2026 in the ordinary shares of Advanced Medical Solutions Group Plc.
Investec Bank plc acted in its capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity during the reported period.
The bank holds a dual role in relation to Advanced Medical Solutions Group Plc, serving as both advisor and joint broker to the company.
According to the filing, Investec sold a total of 120,415 ordinary shares in Advanced Medical Solutions Group Plc on the dealing date.
The highest price received per unit during the sales was 279.5p, while the lowest price received per unit was 279.25p.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this disclosure filing.
Investec confirmed that no indemnity or option arrangements exist that could constitute an inducement to deal or refrain from dealing in relation to the offer.
The bank also confirmed no agreements or understandings exist relating to voting rights or the future acquisition or disposal of any relevant securities tied to derivatives.
The contact listed on the disclosure is Abhishek Gawde, reachable by telephone, with the filing made in accordance with public disclosure requirements under Rule 8 of the Takeover Code.
Public disclosures of this nature are required to be submitted to a Regulatory Information Service, ensuring transparency in dealings during offer periods or potential offer periods.
Advanced Medical Solutions Group Plc is a medical device and advanced wound care company, and regulatory filings of this kind reflect ongoing compliance obligations during sensitive corporate activity periods.
